Becton Dickinson (BDX) Shares Outstanding (2009 - 2026)
Becton Dickinson (BDX) posted quarterly Shares Outstanding (Entity) of $280.6 million for Q1 2026, down 2.32% year-over-year from $287.3 million in Q1 2025, and down 1.73% quarter-over-quarter from $285.6 million in Q4 2025.
Becton Dickinson (BDX) Shares Outstanding (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Shares Outstanding (Entity) for 18 consecutive years, with $280.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) fell 2.32% year-over-year to $280.6 million; the TTM figure through Mar 2026 stood at $280.6 million (down 2.32% YoY), while the FY2025 annual figure was $287.6 million, down 0.73% from the prior year.
- Shares Outstanding (Entity) declined to $280.6 million in Q1 2026 per BDX's latest filing, from $285.6 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $290.1 million in Q4 2023 and bottomed at $280.6 million in Q1 2026.
- Historically, Shares Outstanding (Entity) has averaged $286.6 million across 5 years, with a median of $286.3 million in 2023.
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) increased 2.19% — and 2026, when it fell 2.32%.
- Becton Dickinson's Shares Outstanding (Entity) stood at $283.9 million in 2022, then grew by 2.19% to $290.1 million in 2023, then declined by 0.21% to $289.5 million in 2024, then retreated by 1.36% to $285.6 million in 2025, then declined by 1.73% to $280.6 million in 2026.
- Business Quant data shows BDX's Shares Outstanding (Entity) at $280.6 million in Q1 2026, $285.6 million in Q4 2025, and $287.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 354.10 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 274.79 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 486.70 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 145.52 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 857.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 70.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 172.70 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 195.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 517.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | 71.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 274.79 Mn |
| Mar 31, 2026 | 280.64 Mn |
| Dec 31, 2025 | 285.58 Mn |
| Sep 30, 2025 | 287.65 Mn |
| Jun 30, 2025 | 287.17 Mn |
| Mar 31, 2025 | 287.29 Mn |
| Dec 31, 2024 | 289.51 Mn |
| Sep 30, 2024 | 289.76 Mn |
| Jun 30, 2024 | 289.56 Mn |
| Mar 31, 2024 | 289.52 Mn |
| Dec 31, 2023 | 290.11 Mn |
| Sep 30, 2023 | 286.28 Mn |
| Jun 30, 2023 | 286.32 Mn |
| Mar 31, 2023 | 284.29 Mn |
| Dec 31, 2022 | 283.89 Mn |
| Sep 30, 2022 | 285.01 Mn |
| Jun 30, 2022 | 285.44 Mn |
| Mar 31, 2022 | 285.24 Mn |
| Dec 31, 2021 | 284.69 Mn |
| Sep 30, 2021 | 289.29 Mn |